Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Peak Plasma Concentration (Cmax)/Minimum Inhibitory Concentration (MIC) of bedaquiline and levofloxacin with special attention to the sputum conversion in the treatment of multidrug-resistant tuberculosis in Indonesia

PLOS One(2025)10.1371/journal.pone.0336210Source: DataRank Database

The Peak Plasma Concentration (Cmax)/Minimum Inhibitory Concentration (MIC) of bedaquiline and levofloxacin with special attention to the sputum conversion in the treatment of multidrug-resistant tuberculosis in Indonesia is a research paper published in PLOS One (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: goldTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Anggi Gayatri,Indah Suci Widyahening ORCID,Budiman Bela ORCID,Soedarsono Soedarsono ORCID,Iin Maemunah

Live enrichment

PubMed:41474771 PMC:PMC12755803 OpenAlex:https://openalex.org/W7117764666

Universitas Indonesia

Grant: NKB_292

FWCI

0.00

Citation Percentile

0.6%

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0336210&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0336210&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0336210

journalhttps://doi.org/10.1371/journal.pone.0336210

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41474771

Fields of Study

Tuberculosis Research and EpidemiologyPharmaceutical Quality and CounterfeitingAntibiotics Pharmacokinetics and EfficacyHumansLevofloxacinAdultTuberculosis, Multidrug-ResistantFemaleMaleIndonesiaSputumMiddle AgedAntitubercular AgentsDiarylquinolinesMicrobial Sensitivity TestsAgedAdolescentYoung AdultMycobacterium tuberculosisCohort Studies

MeSH Terms

AdolescentAdultAgedAntitubercular AgentsFemaleHumansIndonesiaMaleMicrobial Sensitivity TestsMiddle AgedMycobacterium tuberculosisSputumCohort StudiesTuberculosis, Multidrug-ResistantYoung AdultDiarylquinolinesLevofloxacin

Keywords

BedaquilineLevofloxacinSputumTuberculosisMinimum inhibitory concentrationPlasma concentrationSputum culture

Sustainable Development Goals

SDG 0: Good health and well-being

The Peak Plasma Concentration (Cmax)/Minimum Inhibitory Concentration (MIC) of bedaquiline and levofloxacin with special attention to the sputum conversion in the treatment of multidrug-resistant tuberculosis in Indonesia

FAIR Checklist

Authors (11)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)